APPENDIX F
Committee Biographies
ROBERT LAWRENCE, M.D. (Chair), is the associate dean for professional education and programs and professor of health policy at Johns Hopkins University School of Hygiene and Public Health. Dr. Lawrence is a member of the Institute of Medicine (IOM). Prior IOM committee memberships have included the following: Guidelines on Thyroid Cancer Screening Committee (chair); Committee on Health Care Services in the U.S.-Associated Pacific Basin (chair); Committee on Priorities for Vaccine Development (chair); Committee on Health and Human Rights (chair); Committee on Human Rights of the National Academy of Sciences, National Academy of Engineering, the Institute of Medicine, and the Board on Health Promotion and Disease Prevention (chair). Other memberships include the U.S. Preventive Services Task Force. His expertise and research interests include community and social medicine, human rights, health promotion and disease prevention, evidence-based decision rules for prevention policy, and international health.
JACK EBELER, M.P.A., is senior vice president and director of the Health Care Group at the Robert Wood Johnson Foundation. In 1995 and 1996, he served in the U.S. Department of Health and Human Services as deputy assistant secretary for Planning and Evaluation/Health and then as acting assistant secretary for Planning and Evaluation. Previous positions include principal, Health Policy Alternatives, Inc., vice president at Group Health, Inc. (now HealthPartners), and senior staff associate focusing on Medicare and the budget at the Subcommittee on Health and the Environment of the House Committee on Energy and Commerce (1981–1983). Mr. Ebeler has a Master’s in Public Administration from the John F.Kennedy School of Government at Harvard University,
and a B.A. from Dickinson College in Carlisle, PA. He is a principal in the Council for Excellence in Government, and a member of the National Academy of Social Insurance.
ROBERT J.GENCO, D.D.S., Ph.D. (through May 15, 1999), is distinguished professor and chairman, Department of Oral Biology, and distinguished professor of microbiology, Schools of Dentistry and Medicine, State University of New York (SUNY) at Buffalo. A member of the IOM, Dr. Genco has served on the faculty at SUNY, Buffalo, since 1967. He has also been on staff at Buffalo General Hospital since 1969. Previous memberships include IOM Committee on Career Paths for Clinical Research, and the National Institute of Dental Research Scientific Advisory Panel and Board of Scientific Counselors. He currently chairs the Food and Drug Administration Dental Products Panel and is past chair of the Over-the-Counter Products Subcommittee. His teaching has been in the areas of epidemiology and community dentistry, periodontal biology, microbiology, clinical periodontology, and molecular and cellular bases of immunology. Dr. Genco holds seven patents, is the author of numerous publications, and is the current recipient of several research grants and contracts from the U.S. Public Health Service. Dr. Genco is a member and past president of the International and American Associations for Dental Research (IADR), and a member of the American Association of Immunologists, the American Association for the Advancement of Science (past chair of the Dental Section), and the American Academy of Periodontology. He is presently the editor-in-chief of the Journal of Periodontology and Annals of Periodontology, and is on the editorial boards of several other journals. He was awarded the Gold Medal for Research by the American Dental Association, and the Basic Research in Oral Sciences Award and the Periodontal Research Award from the IADR.
MARTHE R.GOLD, M.D., M.P.H. is the Arthur C.Logan Professor and chair of the Department of Community Medicine and Social Medicine at the City University of New York Medical School. Previous positions were held with the University of Rochester Medical School and the Office of the Assistant Secretary for Health. Dr. Gold served on the Task Force for Health Care Reform in 1993 and the Panel on Cost-Effectiveness in Health and Medicine. She was a consultant and coeditor for the IOM report Summarizing Population Health (1998). Dr. Gold’s scholarship and publications are in the areas of community-oriented primary care, socioeconomic predictors of health, cost-effectiveness analysis, and measurement of health outcomes. Her teaching, at the medical undergraduate and resident levels, has been in the areas of evidenced-based medicine, cost-effectiveness analysis, population health, and clinical preventive services.
BERTRAM L.KASISKE, M.D., is director, Division of Nephrology, Hennepin County Medical Center, and professor of medicine, University of Minnesota. Memberships include the American Society of Transplant Physicians (Board of Directors) and Clinical Practice Guidelines Committee (cochair); Review Committee for National Institute of Allergy and Infectious Diseases Immunopathogenesis of Chronic Graft Rejection (chair); Juvenile Diabetes Foundation International Grant Peer Review Committee; and American Society of Transplant Physicians Patient Care and Education Committee (cochair 1991–1993, chair 1993–1994). Dr. Kasiske is a fellow of the American College of Physicians. He is the recipient of more than five substantial research support grants and the author of numerous articles. Research interests include evidence-based medicine, immunosuppressive drugs and other therapies for transplant patients, and other topics related to transplantation and renal disease.
LAUREN L.PATTON, D.D.S. (from May 20, 1999), is associate professor of dental ecology in the School of Dentistry of the University of North Carolina (UNC) in Chapel Hill. Dr. Patton also served previously as the director of hospital dentistry in that institution. Prior to joining the faculty at UNC in 1990, Dr. Patton served as a clinical staff fellow at the National Institutes of Health (NIH). Dr. Patton is board-certified in oral medicine. Memberships include the American Dental Association, American Association of Hospital Dentists, American Academy of Oral Medicine, and the American Association of Dental Research, among others. She is a fellow of the American Association of Hospital Dentists. Her teaching has been in the area of management of dental patients with systemic disease. She is the author of many peer-reviewed articles and has contributed chapters and monographs to the field. Her major research interests include the oral manifestations of HIV and periodontal disease in persons with HIV/AIDS, oral complications of head and neck cancer therapy, and salivary gland function and dysfunction in patients with systemic disease.
STEPHEN G.PAUKER, M.D., is vice chairman for clinical affairs, Department of Medicine, New England Medical Center, and Sara Murray Jordan Professor of Medicine, Tufts University. Dr. Pauker is a member of the Institute of Medicine. Prior committee memberships have included IOM’s Guidelines on Thyroid Cancer Screening; the Committee to Evaluate the Artificial Heart Program of the National Heart, Lung, and Blood Institute; and Workshops on the National Institutes of Health Consensus Development Process and the Use of Drugs in the Elderly, both within the IOM. His publications and research have focused on screening for cancer and other conditions, applications of clinical decision theory and medical informatics to health policy, technology assessment and the individualization of patient care, cost-effectiveness analysis, clinical cardiology, telemedicine, ethics of various reimbursement models, and efficiency of care delivery.
ROBERT S.STERN, M.D., is professor of dermatology, Harvard Medical School at the Beth Israel Deaconess Medical Center in Boston. His postgraduate and fellowship training includes a residency in dermatology at Harvard-Massachusetts General Hospital and fellowships at the NIH (epidemiology-clinical genetics) and the Harvard Center for Community Health and Medical Care (health services). He has served on the Harvard Medical School faculty since 1976. His research focuses on epidemiology of skin disease with special focus on nonmelanoma skin cancers, psoriasis, and cutaneous drug eruptions. He is particularly interested in risk factors for the development of nonmelanoma skin cancer, the relative cost-effectiveness of alternative therapies, and the assessment of treatment based on patient-oriented outcomes. He is the author of numerous original peer-reviewed publications.